- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02257073
Cognitive-behavioral Treatment for Rheumatoid Arthritis
March 31, 2017 updated by: Yang Min, Chengdu PLA General Hospital
To evaluate the effectiveness of Cognitive-behavioral treatment for people with rheumatoid arthritis
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
150
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sichuan
-
Chengdu, Sichuan, China, 610083
- General Hospital of Chengdu Military Area Command PLA
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosed by rheumatology consultants with RA
Exclusion Criteria:
- severe psychological difficulties
- currently receiving mental health care
- any medical condition that might prevent them from safely exercising (e.g. history of more severe heart, lung or cerebrovascular disease)
- previously attended an education programme
- had a Modified Health Assessment Questionnaire score >2 (score range 0-3), that is severe functional problems
- history of organic brain syndrome
- presence of a psychotic disorder
- presence of other uncontrolled medical disorders
- presence of a major communication disorder, illiteracy
- presence of less than an 8th grade education (due to inability to complete questionnaires)
- presence of a therapeutic dosage of an antidepressant medication, or presence of another autoimmune disease/disabling condition
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: CBT
Cognitive-behavioral treatment
|
|
Sham Comparator: WLT
Waiting in list
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Changes from baseline in disease activity score in 28 joints(DAS28) at 48 weeks
Time Frame: at 0 week, 12 weeks, 24 weeks, 48 weeks
|
at 0 week, 12 weeks, 24 weeks, 48 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2014
Primary Completion (Anticipated)
May 1, 2018
Study Completion (Anticipated)
July 1, 2020
Study Registration Dates
First Submitted
October 2, 2014
First Submitted That Met QC Criteria
October 3, 2014
First Posted (Estimate)
October 6, 2014
Study Record Updates
Last Update Posted (Actual)
April 4, 2017
Last Update Submitted That Met QC Criteria
March 31, 2017
Last Verified
March 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CBRA20140102
- BWS11J067 (Other Grant/Funding Number: "Twelfth Five-Year Plan" Scientific Research Funds Project of Chinese PLA)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rheumatoid Arthritis
-
Janssen Research & Development, LLCWithdrawnActive Rheumatoid Arthritis; Rheumatoid Arthritis
-
Centocor, Inc.CompletedRheumatoid Arthritis, Juvenile
-
AmgenTerminated
-
Children's Hospital Medical Center, CincinnatiNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedJuvenile Rheumatoid ArthritisUnited States
-
AmgenImmunex CorporationCompletedJuvenile Rheumatoid Arthritis
-
National Institute of Arthritis and Musculoskeletal...Children's Hospital Medical Center, CincinnatiCompleted
-
University of PittsburghNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedRheumatoid Arthritis | Juvenile Rheumatoid ArthritisUnited States
-
University of Missouri-ColumbiaCompletedJuvenile Rheumatoid ArthritisUnited States
-
Assistance Publique - Hôpitaux de ParisSociete Francaise de RhumatologieRecruiting
-
Amsterdam UMC, location VUmcEuropean CommissionCompletedRheumatoId ArthritisNetherlands, Germany, Portugal, Italy, Hungary, Romania, Slovakia
Clinical Trials on Cognitive-behavioral treatment
-
University of UtahNational Institute on Drug Abuse (NIDA)Completed
-
Philipps University Marburg Medical CenterCompleted
-
Boston University Charles River CampusNational Institute of Mental Health (NIMH)CompletedObsessive-Compulsive DisorderUnited States
-
Stanford UniversityCompletedDepression | Anxiety | Posttraumatic Stress Disorder | Acute Stress DisorderUnited States
-
Ruhr University of BochumUniversity of British Columbia; Friedrich-Alexander-Universität Erlangen-NürnbergCompletedHypoactive Sexual Desire DisorderGermany
-
Karolinska InstitutetErsta DiakoniCompletedCognitive Behavioral Therapy
-
Temple UniversityNational Cancer Institute (NCI)Unknown
-
Universidad Nacional Autonoma de MexicoIstituto Auxologico Italiano; Medica Sur Clinic & FoundationUnknown
-
Technische Universität DresdenFederal Ministry of HealthUnknownCannabis Use DisordersGermany
-
Leiden University Medical CenterZonMw: The Netherlands Organisation for Health Research and Development; University...Unknown